SCHEMBL22096810

SCHEMBL22096810

CC(C)(C)c1ncccc1/C=N/O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX12 P18054 1/20 0.49
▸ FGF23 Q9GZV9 2/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ MAPT P10636 3/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ HTT P42858 3/20 0.37
▸ TSHR P16473 2/20 0.37
▸ HPGD P15428 6/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ HSP90AA1 P07900 1/20 0.35
▸ LMNA P02545 2/20 0.35
▸ USP2 O75604 1/20 0.34
▸ RIPK1 Q13546 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22397164 0.82 ALDH1A1 (0.44) ALOX12FGF23ALDH1A1MAPTHTT
SCHEMBL9275525 0.82 ALDH1A1 (0.44) ALOX12FGF23ALDH1A1MAPTHTT
SCHEMBL22397166 0.82 ALDH1A1 (0.44) ALOX12FGF23ALDH1A1MAPTHTT
SCHEMBL21709897 0.76 SMN1; SMN2 (0.39) ALOX12FGF23ALDH1A1MAPTSMN1; SMN2
SCHEMBL2120978 0.76 FGF23 (0.55) ALOX12FGF23ALDH1A1MAPTSMN1; SMN2
SCHEMBL3927387 0.76 FGF23 (0.55) ALOX12FGF23ALDH1A1MAPTSMN1; SMN2
SCHEMBL20597363 0.73 FGF23 (0.61) ALOX12FGF23ALDH1A1MAPTHTT
SCHEMBL19880469 0.73 ALDH1A1 (0.49) ALOX12FGF23ALDH1A1MAPTHTT
SCHEMBL19769027 0.73 ALDH1A1 (0.49) ALOX12FGF23ALDH1A1MAPTHTT
SCHEMBL509268 0.72 AMY1A (0.57) ALOX12FGF23ALDH1A1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10875839-B2 Somatostatin modulators and uses thereof Crinetics Pharmaceuticals, Inc. (US) 2020-12-29 — — US disclosed
US-20200190053-A1 SOMATOSTATIN MODULATORS AND USES THEREOF Crinetics Pharmaceuticals, Inc. 2020-06-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200190053-A1 SOMATOSTATIN MODULATORS AND USES THEREOF SSTR5, SSTR2, SSTR4 ALOX12 2656/4885FGF23 194/4885ALDH1A1 4626/4885
US-10875839-B2 Somatostatin modulators and uses thereof SSTR5, SSTR2, SSTR4 ALOX12 2656/4885FGF23 194/4885ALDH1A1 4626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback